Invest in Emcure Pharma IPO

Plus
Plus

Emcure Pharma IPO is here! Book built issue worth ₹1,952.03 Cr.

Plus
Plus

Open: July 3, 2024 Close: July 5, 2024 Listing: July 10, 2024

IPO Timeline:

Plus
Plus

Face Value: ₹10 per share Price Band: ₹960 to ₹1008 per share Minimum Lot Size: 14 Shares

IPO Details:

Plus
Plus

Retail Investors: ₹14,112 for 14 shares S-HNI: ₹211,680 for 210 shares B-HNI: ₹1,001,952 for 994 shares

Investment Info:

Plus
Plus

Fresh Issue: 0.79 Cr shares, ₹800 Cr Offer for Sale: 1.14 Cr shares, ₹1,152.03 Cr

Issue Breakdown:

Plus
Plus

Pre-issue Holding: 98.90% Employee Discount: ₹90 per share

Promoter & Employee Info:

Plus
Plus

Revenue FY24: ₹6,715.24 Cr PAT FY24: ₹527.58 Cr

Financials:

Plus
Plus

Repayment of borrowings General corporate purposes

Use of Funds:

Plus
Plus

Ranked 13th in domestic sales (MAT Sep 2023) 5 R&D facilities, 552 scientists 13 manufacturing facilities in India

Market & R&D Presence:

Plus
Plus

Fully priced based on FY24 earnings Potential for medium to long-term investment

Analyst Review & CTA:

Ready to invest?

Plus
Plus

Understand the risks associated with trading and investment in securities markets. Read our disclaimer for a better understanding.

Disclaimer

Plus
Plus